Close Menu

SAN FRANCISCO – Roche and Illumina said at the JP Morgan Healthcare Conference here on Monday that they have formed a partnership focused on driving the adoption of next-generation sequencing assays for oncology.

Under the 15-year, non-exclusive agreement with Roche, Illumina will grant Roche rights to develop and distribute in vitro diagnostic tests on Illumina's NextSeq 550Dx System, as well as on its future portfolio of Dx-branded sequencing systems, including the forthcoming NovaSeqDx.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.